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KEY POINT

From March 4 to April 10, 2020, Northwell Health Laboratories identified SARS-CoV-2 infection in
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26,735 of 46,793 tested persons; these data provide detailed insights into the demographics,

Ac

geographic spread, and delivery of health care for SARS-CoV-2 in the New York area.
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ABSTRACT
Background
In March 2020, the greater New York metropolitan area became an epicenter for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The initial evolution of case incidence
has not been well characterized.
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Methods

Northwell Health Laboratories tested 46,793 persons for SARS-CoV-2 from March 4 through April 10.
The primary outcome measure was a positive reverse-transcription-polymerase-chain-reaction (RTPCR) test for SARS-CoV-2. The secondary outcomes included patient age, sex, and race if stated;
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dates the specimen was obtained and the test result; clinical practice site sources; geo-location of

M

patient residence; and hospitalization.
Results
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From March 8 through April 10, a total of 26,735 of 46,793 persons (57.1%) tested positive for SARS-
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CoV-2. Males of each race were disproportionally more affected than females above age 25, with a
progressive male predominance as age increased. Of the positive persons, 7,292 were hospitalized
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directly upon presentation; an additional 882 persons tested positive in an ambulatory setting

Ac

before subsequent hospitalization, a median of 4.8 days later. Total hospitalization rate was thus
8,174 persons (30.6% of positive persons). There was a broad range (greater than 10-fold) in the
cumulative number of positive cases across individual zip codes following documented first case
incidents. Test positivity was greater for persons living in zip codes with lower annual household
income.
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Conclusions
Our data reveal that SARS-CoV-2 incidence emerged rapidly and almost simultaneously across a
broad demographic population in the region. These findings support the hypothesis that SARS-CoV-2
infection was widely distributed prior to virus testing availability.
KEYWORDS
Coronavirus Disease 2019 (COVID-19)
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INTRODUCTION
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has presented major
challenges to health care institutions globally. A challenge in identifying these patients is the speed
at which patients can develop severe infections following exposure, and the widely varying
estimates for case incidence of those infected (1). Shortly after the first case of SARS-CoV-2 infection
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was identified in New York State (March 1, 2020), Northwell Health, a large integrated health care
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system that serves the greater New York City region, began testing for SARS-CoV-2 viral RNA. Our
first positive case was found on March 8 for a specimen collected on March 4. Over the next five
weeks, Northwell Health Laboratories (NWL) identified positive cases of SARS-CoV-2 in 26,735 of the
180,458 persons (14.8%) identified in New York State (2). With these data, we sought to understand
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the spread of SARS-CoV-2 through the greater New York metropolitan region.
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METHODS

The population for this study was tested for SARS-CoV-2 by NHL from March 4 (first
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specimen collection date) through April 10, 2020 (last test result date). As NHL is an integrated
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laboratory network (3), SARS-CoV-2 testing was made available across the entire Northwell health
system. NHL used three real-time reverse-transcription-polymerase-chain-reaction (RT-PCR) tests:

ce

starting March 7 a diagnostic panel modified from the US Food and Drug Administration (FDA)
method by the New York State Department of Health (NYSDOH); starting March 11 the ePlex(R)

Ac

(GenMark Diagnostics, Inc.; Carlsbad, CA); and starting March 17 the Panther Fusion System(R)
(Hologic, Inc.; Marlborough, MA) automated methods. These tests were authorized for emergency
use by the FDA and NYSDOH, and were validated by NHL to detect SARS-CoV-2 RNA in
nasopharyngeal and oropharyngeal swabs transported in liquid media and in sputum specimens. The
median time between specimen collection and the test result was 1.7 days (IQR = 1.2 – 2.2).
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De-identified patient data were obtained from the NHL Information System (Cerner, Inc.,
Kansas City, MO). These data included patient test result, age, sex, race, dates of when the specimen
was obtained and the test resulted, and zip code of patient residence. Hospitalization data were
obtained from the Sunrise Clinical Manager electronic health record (Allscripts, New York, NY).
Geographic information was mapped using custom MATLAB code for plotting dots on a fixed map
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image.
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Publicly available data sources used for analyses are given in the Supplement. Data

compilation and statistical analyses were done using spreadsheets (Excel, Microsoft, Inc.; Redmond,
WA), R (version 3.2.2), SPSS 26 (International Business Machines, Armonk, NY), MATLAB

(MathWorks; Natick, MA), JMP (SAS Institute, Cary, NC) and ad-hoc Perl scripts. Statistical
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comparisons for data in Figure 5, Supplemental Figure 1 and Supplemental Table 1 was by one-way
analysis-of-variance, in Figures 6 and 7 and Supplemental Figure 3 by linear correlation and t-test of
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LOG10 transformed data, and in Figures 8 and 9 by ChiSquare. The Northwell Health Institutional
Review Board approved this as minimal-risk research using de-identified data collected for routine

RESULTS
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clinical practice and waived the requirement for informed consent.
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Geographic Distribution

Ac

From March 2 through April 10, 2020, a total of 345,838 SARS-CoV-2 tests were performed

in the greater New York City region (the five counties of New York City plus Nassau, Suffolk, and
Westchester) (3), of which 51,074 tests (14.8%) were resulted by NHL. Correcting for repeat testing
on individuals, this represented 46,793 unique persons residing in 853 zip codes, 44,723 (95.6%) of
whom resided in 456 of the 644 zip codes of this region. Of these 46,793 persons, Northwell testing
identified 26,735 persons (57.1%) with at least one test positive for SARS-CoV-2. Northwell’s first
positive specimen was from a patient-associated zip code in Nassau County; the test sample was

6

obtained March 4 when the patient presented to a Northwell hospital emergency department.
Within 3 days, Northwell hospitalized patients from five additional zip codes in Nassau, Queens,
Manhattan, Staten Island and Westchester were identified as being SARS-CoV-2 positive. By April 10,
SARS-CoV-2 positive patients were identified in 455 of the 456 zip codes in our service area from
which persons had been tested by Northwell.
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The cumulative distribution of positive patients by April 10 in individual zip code areas is
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shown in Figure 1 (a time-lapse chronologic display of case accumulation per zip code is available as
a Supplementary Video). SARS-CoV-2 was already widespread in our geographic region during the
first week of testing, based on the almost simultaneous appearance of SARS-CoV-2 patients residing
in widely dispersed zip codes. However, different zip code areas with the same starting date

an

displayed markedly diverse case burden over the course study period, as shown by the growth of
cumulative case incidence (Figure 2A). This diversity is further quantified (Figure 2B): the

M

percentage of the population cumulatively testing positive per zip code is plotted as a function of the
days elapsed after identification of the first case in its respective zip code area (each circle denotes

pt
e

d

one zip code). On this semi-log plot, a 10-fold range in cumulative case incidence is observed across
different zip codes for a fixed appearance date of the first case. The symmetric distribution of the
points around the median (blue line) on a log scale indicates a long-tailed, log-normal type

ce

distribution, with a few extreme zip codes showing large percentages affected. One data point is

Ac

denoted as an example (Bayville, NY) (4)
Clinical Practice Site Sources
Among the 26,735 positive patients from March 4 to April 10: 5,576 (20.9%) test samples
were obtained during an emergency department evaluation; 6,584 (24.6%) as part of an admissionto-hospital order set, including admission to an intensive care unit; 7,493 (28.0%) from urgent care
centers (mostly Northwell Health GoHealth facilities); 5,473 (20.5%) from other ambulatory practice
locations; 1,292 (4.8%) from skilled-nursing and assisted-living facilities; and 317 (1.2 %) from
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Northwell Health Employee Health Services. The daily distribution of testing location is shown in
Figure 3. At first, predominantly hospitalized patients were tested (inpatient floor or intensive care
unit). As case incidence and familiarity with SARS-CoV-2 clinical presentation increased, the fraction
of testing dedicated to hospitalized patients decreased to approximately 20%, while testing in
emergency departments, urgent care centers and other outpatient settings increased.
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Daily Northwell SARS-CoV-2 testing volumes are shown in Figure 4A. The peak aggregate daily
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case incidence of SARS-CoV-2 occurred on April 1, with 1,862 positive cases. Figure 4B shows SARSCoV-2 % test positivity rates beginning on March 13 when testing volumes began to increase
dramatically; peak % test positivity rates were the last week of March. Northwell daily test %
positivity rates substantially exceeded regional rates, particularly from March 16 to 21, with the final
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cumulative % positive rate on April 10 being 54.5% (Northwell) vs. 46.1% (service area); a ratio of

M

1.18 (see Supplemental Figures 1 and 2, Supplemental Table 1).
Demographics.

d

During the study, 24,058 females and 22,610 males were tested (no sex information was
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available for 125 persons). The age distribution of testing by gender is given in Figure 5A. Although
the age distribution of persons tested generally follows the patterns reported in the 2010 US census,

ce

persons under 35 years were markedly under-represented (p = 0.021). Test positivity rates
increased progressively with age (p < 0.0001), with males showing higher rates (p = 0.003) except for

Ac

the earliest ages (less than 5) or the latest (greater than 85 years of life);.
We estimated the population-normalized distribution of the percentage of population

affected by age and gender (Figure 5B). Cumulative Northwell SARS-CoV-2 positive cases across our
service area accounted for 17% of the total cases reported in New York State. The estimated % of
the regional population confirmed as SARS-CoV-2 positive (for females and males) was well below
1% for under age 25. For females age 25 and above, estimated case distribution rose steadily from

8

1.7% to 2.6% through age 84 and was 4.7% for age 85 and above. For males age 25 and above,
estimated case incidence rose from 1.6% at age 25 to 4.4% through age 84 and was 6.0% for age 85
and above. Thus, in this population-normalized distribution, males were disproportionately more
affected than females above age 25 (p<0.001).
We next examined the potential impact of socioeconomic factors and race. Figure 6A shows

t

the % of persons tested by NWL in each zip code, as a function of zip code average annual household
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income; no significant relationship is evident. Figure 6B shows SARS-CoV-2 % test positivity versus
average annual household income by zip code. From $25,000 to $125,000 per annum, there is a
strong negative correlation (R2 = 0.35, p<0.0001). From $125,000 to $800,00 per annum, there is a
slightly positive trend, which is not statistically significant. Supplemental Figure 3 shows that while
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the % of the population tested for SARS-CoV-2 by NWL did not correlate with zip code population
and population density, there was a positive correlation of zip code % test positivity with these

M

variables. Supplemental Figure 4A-B shows that zip code average annual household income
inversely correlated with zip code population and population density. However, when our testing
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data was normalized to the respective fraction of the New York State-reported SARS-CoV-2 testing
that NWL performed (Supplemental Figure 4C-F), the correlation of % test positivity with zip code
average annual household income was eliminated. We therefore examined the relationship of NWL
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testing to zip code % persons below Poverty Level. Figure 7A shows the relationship of % of the

Ac

population tested by Northwell per zip code to this variable, for the two counties in New York City
for which such data were available and NWL testing represented greater than 20% of all SARS-CoV-2
testing performed. For Queens county but not Richmond county (Staten Island), there was a
significant negative correlation between % testing versus % Poverty Level (R2 0.34, p<0.02). Figure
7C shows the % of persons testing positive by Northwell for SARS-CoV-2 as a function of % Poverty
Level. Again for Queens, there was a negative trend in % testing positive, but it did not reach
significance (Figure 7C; R2 0.26, p = 0.07).
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Collectively, these economic data suggest that persons from lower income, higher
population density zip codes had access to NWL-based SARS-CoV-2 testing that was comparable to
the access of persons from higher income, lower population zip codes, but exhibited higher SARSCoV-2 % test positivity rates. However, our population sampling from these respective zip codes
may have differed from the overall regional SARS-CoV-2 testing as reported by New York State. This
premise is supported by the higher % test positivity rates experienced by NWL, particularly during

us
cr
ip

t

the latter half of March. This may have resulted from differential presention of higher acuity

patients from lower income zip codes to Northwell during the early phase of the pandemic, and
hence differential sampling of the regional population. We cannot exclude statistical sampling
variability as a confounding variable.
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Figures 7B and 7D show the relationship of % of the population tested by NWL and % test
positivity, respectively, as a function of the % not-White population per zip code. Statistically

M

significant relationships are not identified, although Queens appears to reveal positive trends (Figure
7B: R2 0.13, p = 0.39; Figure 7D: R2 0.15, p = 0.31). Looking then at our data specifically, information
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on “White”, “Black”, or “Asian” racial status was available for 17,574 (37.6%) of the 46,793 persons
tested by NWL, with only 244 patients (0.5%) reporting “Hispanic” or “Indian”, and unknown racial
status for the remainder. Race information was patient-reported for less than 30% of persons below

ce

age 40 years, progressively rising to approximately 65% for the older age groups (see Supplemental
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Figure 5). Figure 8 shows test positivity by gender and race. For females, Asian and White test
positivity rates are similar, and less than Black females. For males, Asian and Black test positivity
rates are similar, and greater than White males. In aggregate, test positivity was highest in Blacks,
followed by Asians and Whites (p<0.0001). The respective sex differences in test positivity between
the three racial groups also were statistically significant (p<0.0001).
The relationships of test results, age, and race, are further shown in Figure 9. The mean age
(±SEM) of test-negative persons was 44.4±0.9 years for Asians, 47.5±0.6 years for Blacks, and
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53.1±0.3 years for Whites. The mean age (±SEM) of test-positive persons was 56.9±0.6 years for
Asians, 57.2±0.3 years for Blacks, and 61.8±0.2 years for Whites. Thus, test-positive persons were
older by several years for all three races (p<0.0001). Supplemental Tables 1 and 2 provide
additional information about race, gender, age, and SARS-CoV-2 test results.
Hospitalizations
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Figure 10 shows the testing locations and patient disposition for our study population,
with subsequent hospitalizations monitored through May 16, 2020. 8,174 (30.6%) of the
26,735 SARS-CoV-2 positive patients were admitted to monitored Northwell hospitals; 7,292
of whom were admitted directly upon presentation, and 882 from outpatient status, the latter a
median of 4.8 days after the positive test sample had been obtained. The latter group
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represents 4.5% of all ambulatory patients who tested positive for SARS-CoV-2. The median

M

time between collection of their first SARS-CoV-2 positive test sample and their hospitalization was 4.8 days (IQR = 2.5 – 8.2; 95th percentile = 30.7 days). Notably, 486 (10%) of the

d

patients tested in a hospital-based emergency department and released as ambulatory patients
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were ultimately admitted to hospital. Conversely, 396 (3%) of the 14,575 SARS-CoV-2
positive patients who had been tested in an ambulatory setting were subsequently admitted to
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hospital.

Ac

DISCUSSION

These results indicate that SARS-CoV-2 infection was already geographically widespread in

the greater New York City region when testing began in early March 2020 (5), a premise supported
by sequencing of viral genomes obtained from the New York area (6) and by modeling of the
pandemic outbreak (7). Given literature estimates of serial intervals between infections (4 to 6 days,
(1,8) and R0 values of 2.6 to 3.2 during the exponential period of disease outbreak (9), it is unlikely
that six cases from five geographically dispersed zip codes over the next four days could be
explained by secondary infections from the first March 4th case, or from exposure to the first
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documented case in the New York City area on March 1 in Westchester County (10). It is more likely
that the initially observed cases in our study originate from multiple infection sources already
present across the geographical area when testing began (7). While the initial patients tested by
NWL had already been admitted to hospital for respiratory illness, the rapid increase in SARS-CoV-2
testing from emergency departments, urgent care centers and ambulatory practice sites reflects the
realization that patients presenting with respiratory illness were likely to have this illness (11). As
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reported elsewhere, males were more likely to have a positive test, and the % test positivity rates
increased markedly with age for both males and females (12).

Our data reveal large spatial heterogeneity in disease progression across the greater New
York City region, in keeping with the geographic diversity found in countries across the globe (13,14).

an

We observe that current epidemiological models for contagion (e.g., (15)) largely stratify by
demographics, infection status, and location at the county level, while micro-local geography has not

M

been included. Our observations indicate that for accurate modeling of the progression of a
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e

important to incorporate.

d

pandemic through a geographic region, long-tailed spatial heterogeneity at a small scale will likely be

For this entire study population of 26,735 patients testing positive for SARS-CoV-2, a total of

ce

8,174 persons (30.6%) were admitted to the hospital. This is comparable to hospitalization rates
reported by the Centers for Disease Control for cases of SARS-CoV-2 disease, for which case

Ac

hospitalization statistics are known (6,354 of 24,925 cases; 25.5%; (16)). Our study provides the
additional information that ambulatory patients testing positive for SARS-CoV-2 (either tested-andreleased from emergency departments or otherwise tested at an ambulatory location) remain at risk
for subsequent hospitalization. Our study constitutes a minimal estimate of outpatient
hospitalization rates, since we did not include patients that might have been admitted to other
hospitals.
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The relationship of COVID-19 in the United States with socioeconomic determinants of
disease is under intense investigation (17, 18). In an analysis of COVID-19 case positivity in five
major U.S. municipalities including New York City (19), significant positive correlations were found
between zip code % SARS-CoV-2 positive rates and zip code population density, % of persons who
were not White, and % of persons above age 65. Recognizing that a high proportion of SARS-CoV-2
infected individuals who die have comorbid conditions (16), the strong negative correlation of these
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comorbidities (obesity, diabetes, hypertension, kidney disease, chronic obstructive pulmonary

disease) with median household income by U.S. census tracts is striking when illustrated graphically
(20). Our finding of a strong negative correlation between persons testing positive for SARS-CoV-2
and average household income by zip code for the range of $25,000 to $125,000 per annum

an

provides further supporting evidence for the importance of these socioeconomic factors.

Owing to incompleteness in our patient-level data on racial status, care must be taken in

M

drawing conclusions about the impact of race on SARS-CoV-2 burden in our regional community,
particularly given the absence of information on Latino/Hispanic persons. For the 37.7% of persons
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tested who did report their race (almost all as Asian, Black, or White), Blacks had the highest
aggregate % test positivity rates. The male predominance of test positivity was true for all three
races, but was most pronounced for Blacks. For both both genders and for all three races, the age

ce

distribution of persons who tested positive was significantly older than those who tested negative.

Ac

We note that reporting of SARS-CoV-2 patient race and ethnicity is now required (21).
Limitations. The information reported here only includes the results from one integrated laboratory
network serving the parent health system, and does not include other laboratory results, home
tests, or other regional testing that were conducted on study subjects during the study period. The
number of SARS-CoV-2 tests performed during these initial weeks was a function of the progressively
increasing test capacity at Northwell Health Laboratories from March 8 – April 10, 2020, as limited
by the availability of reagents and supplies for the performance of these tests, and may have
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influenced ability to detect cases in the region. We were not using zip codes for areal analysis,
seeking instead to use zip codes as a mechanism to explore the chronologic timing of micro-local
geographic heterogeneity. However, these results may be limited in their generalizability, because
of restricted sample size and the potential selection bias that zip code grouping can introduce into
geo-epidemiologic analyses (22). Reliance on the 2010 census may also introduce inaccuracy in
estimates of population cumulative case incidence, to the extent that the regional population has
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changed in the ensuing 10 years. Reliance on publicly available 2017 data from the U.S. Internal
Revenue Service and from the 2010 census permits correlative statements only to be made about
the relationship of SARS-CoV-2 cumulative case incidence and geolocalized socioeconomic and racial
factors. Lastly, the incompleteness of our patient-level data on racial status limits our ability to

an

make statements about the impact of race on SARS-CoV-2 case incidence.

M

CONCLUSIONS

In early March, positive SARS-CoV-2 cases were identified simultaneously across the region, with

d

higher incidences in men and older persons. Our geographic analysis supports the hypothesis that
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SARS-CoV-2 infection was widely distributed in the greater New York City region when virus testing
became available in early March. Test % positivity rates were higher in patients from zip codes with

ce

higher population density and lower average annual household income. Our data emphasize the
importance of detailed chronologic, geospatial and demographic analysis of regional populations as

Ac

part of understanding the evolution of SARS-CoV-2 as a pandemic event.
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FIGURE LEGENDS
Figure 1. Spatial distribution of the local percentage of population infected and its progress with
time. Each circle represents a New York State zip code area, and its size is proportional to the

t

number positive cases normalized by the population in the zip code. The color of each dot
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represents the first day that cases were detected (the hues range from red to blue, corresponding to
the time period March 4 - April 10). The first cases appeared early in most zip codes, denoted by
their predominantly red color. A dynamic representation of the growth leading to this map is

an

available in a supplementary video.

Figure 2. Variation in cumulative case incidence by zip code. (A) Cumulative case incidence by zip

M

code, as a function of calendar date. Five zip codes are highlighted in bold, to show the diversity in
case accrual. (B) Cumulative cases on April 10 as a function of days elapsed since detection of the

d

first case. Each symbol represents a single zip code. The x-axis value is calendar date the first case in
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e

a given zip code appeared. The left y-axis value is the cumulative SARS-CoV-2 case incidence, as a
fraction of population in that zip code on April 10. 501 Zip code areas are represented. The blue line

ce

connects the median values of the fraction of population infected across zip codes, as a function of
the date of first case incidence. The diversity in case accumulation per zip code is shown by the wide

Ac

dispersion of symbols on this semi-log plot, for the fixed date of the first case in any given zip code.
The red asterisks and the right y-axis denote the number of zip codes acquiring a “first case” on any
given calendar day.
Figure 3. Clinical site of origin for SARS-CoV-2 test specimens, as a percentage of specimens received
each day by Northwell Health Laboratories. The percentage of cases for the first days of sample
receipt (March 4-6, 2020) are from the hospital setting (inpatient unit, intensive care unit, or
emergency department). Starting March 7, samples began to be received from urgent care and
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ambulatory practice settings; from nursing homes starting March 12; and from Northwell employee
health services starting March 17.
Figure 4. Daily SARS-CoV-2 testing data. (A) Test volumes, on the basis of the daily receipt of
nasopharyngeal swab samples, daily resulting of tests, and daily number of positive tests. The first
sample was received on March 4, and the first tests were resulted on March 7. (B) Daily % test
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positivity rates are shown starting March 13, as obtained from a hospital setting (inpatient unit,
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intensive care unit, or emergency department), urgent care, or other (predominantly ambulatory
practice sites, with a small fraction of cases from nursing homes and Northwell employee health
services; see Figure 3).

Figure 5. Demographics of tested population. (A) Left axis: Number of persons tested by age and

an

gender. Each bar represents one year of age. The bar height represents the total number of persons

M

of the particular age who were tested by Northwell Health Laboratories, and the color represents an
interspaced histogram of females (red) and males (blue). Right axis: Test percent positivity rates, as a

d

function of age; females (red) and males (blue). (B) Percentage of persons of the same age and sex in

pt
e

the State of New York expected to be infected by SARS-CoV-2. Each bar represents a hemidecile age
bracket; female (red) and male (blue) are shown as separate bars. The bar height represents the

ce

percentage of New York State persons of the particular age and sex estimated to be infected with
SARS-CoV-2, based on the number of positive results obtained by Northwell Health Laboratories,

Ac

corrected on a per-county basis for the fraction of the total State SARS-CoV-2 testing performed by
Northwell Health Laboratories, and then normalized to respective county population demographics
using the 2010 census (8). The line represents the male to female odds ratio for each hemidecile age
bracket. The horizontal straight reference line at the value of 1 denotes an equal odds of men and
women being infected with SARS-CoV-2.
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Figure 6. Northwell SARS-CoV-2 testing by Average Household Income. Each point in these plots
represents a zip code. (A) Logarithmic plot of the % of population in each zip code tested by
Northwell Health Laboratories for SARS-CoV-2, as a function of average annual household income
per zip code, based on US 2017 Census data. Log values are displayed for the y-axis and along the
upper x-axis; actual values for annual income are shown along the lower x-axis. (B) Logarithmic plot
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of the % of SARS-CoV-2 positive persons tested by Northwell Health Laboratories, as a function of
average annual household income. Zip codes are from the four counties in which Northwell Health
Laboratories tested greater than 10% of the total county population tested (Queens, Nassau, Suffolk,
Richmond counties), and in which at least 10 persons were tested. A total of 36,177 persons in 217

an

zip codes are represented.

Figure 7. Northwell SARS-CoV-2 testing by Socioeconomic Factors. Each point represents a zip code.

M

(A) Linear plot of zip code % of population tested as a function of % of persons below Poverty Level.
(B) Linear plot of zip code % of population tested as a function of % of persons not-White. (C) Linear
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plot of the zip code % of SARS-CoV-2 positive persons as a function of the % of persons below
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Poverty Level. (D) Linear plot of the zip code % of SARS-CoV-2 positive persons as a function of the
% of persons who were not-White. Inclusion criteria for all panels were regional counties for which
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Northwell Health Laboratories provided greater than 10% of SARS-CoV-2 testing, and individual zip
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codes with at least 10 tested persons. The data represent 26.2% of all SARS-CoV-2 tests performed
in Richmond County from March 4 to April 10, 2020 (4,059 persons, 12 zip codes), and 21.4% of all
tests performed in Queens County (9,831 persons, 49 zip codes).
Figure 8. SARS-CoV-2 Test Results by Race and Gender. Mosaic plots are shown for female (left)
and male (right) patients of known race, with the number of persons indicated by the width and
height of the groupings; actual number of persons testing SARS-CoV-2 positive (red) or negative
(blue) in each race/gender subgroup (%) are shown.
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Figure 9. SARS-CoV-2 Test Results by Race and Age. (A) Box-and-whisker plot of negative test results
by age for Asian (n=594), Black (n=1,461), and White (n=5,075) persons, with mean and 95%
Confidence Intervals shown. The separation of the vertical displays reflects the number of persons
tested per racial group. The adjacent histograms show the relative age distribution of negative test
results for each race. (B) Cumulative case distribution by age for Asian, Black, and White persons
testing negative for SARS-CoV-2. (C) Box-and-whisker plot of positive test results by age for Asian
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(n=979), Black (n=3,073), and White (n=6,385) persons. (D) Cumulative case distribution by age for
Asian, Black, and White persons testing positive for SARS-CoV-2.

Figure 10. SARS-CoV-2 Testing Locations and Disposition of SARS-CoV-2 Positive Patients. The
disposition of the 26,735 patients testing positive for SARS-CoV-2 is shown, both on the basis of the

an

location their test sample was obtained, and whether they were immediately admitted to hospital,
or admitted after being found to be positive as outpatients. Subsequental hospitalizations of SARS-

M

CoV-2 outpatients were monitored through May 16, 2020. Percentage values given within the boxes
are the % of 26,735 positive patients. Percentage values given next to the arrows represent the sub-
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fraction of the immediately prior box, with the exception of the 4.5% which represents the
proportion of all SARS-CoV-2 positive outpatients subsequently admitted to hospital [882 divided by
(4,868 ED treat-and-release plus 14,575 ambulatory-based, equals 19,443 patients)]. ED, Emergency
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Department.
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